Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

JAMA Neurol.

Mielke MM, Hagen CE, Wennberg AMV, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Jack CR Jr, Petersen RC, Dage JL

doi: 10.1001/

RECOMMENDED

Alzheimer’s DiseaseDementia

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

doi: 10.1093/brain/awaa054.

Aging and Cognitive Functions

Acute plasma tau relates to prolonged return to play after concussion

Neurology.

Gill J, Merchant-Borna K, Jeromin A, Livingston W, Bazarian J

doi: 10.1212/

Alzheimer’s Disease

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Lancet Neurol.

Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, Schöll M, Massarweh G, Soucy JP, Höglund K, Brinkmalm G, Mattsson N, Palmqvist S, Gauthier S, Stomrud E, Zetterberg H, Hansson O, Rosa-Neto P, Blennow K

doi: 10.

Aging and Cognitive FunctionsDementia

Diagnostic performance of new and classic CSF biomarkers in age-related dementias

Aging (Albany NY).

Marchegiani F, Matacchione G, Ramini D, Marcheselli F, Recchioni R, Casoli T, Mercuri E, Lazzarini M, Giorgetti B, Cameriere V, Paolini S, Paciaroni L, Rossi T, Galeazzi R, Lisa R, Bonfigli AR, Procopio AD, De Luca M, Pelliccioni G, Olivieri F

doi: 10.18632/aging.101925.

Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5

Brain.

Marelli C, Lamari F, Rainteau D, Lafourcade A, Banneau G, Humbert L, Monin ML, Petit E, Debs R, Castelnovo G, Ollagnon E, Lavie J, Pilliod J, Coupry I, Babin PJ, Guissart C, Benyounes I, Ullmann U, Lesca G, Thauvin-Robinet C, Labauge P, Odent S, Ewenczyk C, Wolf C, Stevanin G, Hajage D, Durr A, Goizet C, Mochel F

doi: 10.1093/brain/awx297.

COMMENTED

Alzheimer’s DiseaseDementia

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts

JAMA Neurol.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB

doi: 10.1001/

Multiple Sclerosis

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

JAMA Neurol.

van der Vuurst de Vries RM, Mescheriakova JY, Runia TF, Jafari N, Siepman TA, Hintzen RQ

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsDementia

Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia

Curr Treat Options Neurol.

Sheikh-Bahaei N, Sajjadi SA, Pierce AL

doi: 10.1007/

Related content

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

Acute plasma tau relates to prolonged return to play after concussion

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Diagnostic performance of new and classic CSF biomarkers in age-related dementias

Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia